The plight of the Monaco microstate in the GBD 2023 study | Synapse
May 15, 2026
The plight of the Monaco microstate in the GBD 2023 study
Key Points
This research aims to evaluate the health metrics and burden of disease in the microstate of Monaco within the context of the Global Burden of Disease (GBD) 2023 study.
Analyzed health metrics from the GBD 2023 database specific to Monaco.
Compared findings with broader regional and global health data.
Assessed demographic factors influencing health outcomes.
Identified unique health challenges faced by Monaco, including high costs of healthcare.
Reported specific disease burdens with metrics demonstrating disparities compared to larger populations.
Highlighted the need for targeted health policies considering Monaco’s microstate status.